Why Paracetamol Works: New Discovery Ends Longstanding Mystery
en-GBde-DEes-ESfr-FR

Why Paracetamol Works: New Discovery Ends Longstanding Mystery


A new study from Hebrew University reveals that paracetamol doesn’t just work in the brain—it also blocks pain at its source by acting on nerve endings in the body. The researchers found that its active metabolite, AM404, shuts down specific sodium channels in pain-sensing neurons, stopping pain signals before they reach the brain. This discovery not only reshapes our understanding of how one of the world’s most common painkillers works, but also opens the door to developing safer, more targeted pain treatments.

A breakthrough study from the Hebrew University of Jerusalem, published this week in the prestigious journal PNAS (Proceedings of the National Academy of Sciences USA), reveals a previously unknown peripheral mechanism by which paracetamol (also known as acetaminophen, Tylenol®, or Panadol®) relieves pain.

The study was led by Prof. Alexander Binshtok from the Hebrew University’s Faculty of Medicine and Center for Brain Sciences (ELSC) and Prof. Avi Priel from its School of Pharmacy. Together, they uncovered a surprising new way that paracetamol—one of the world’s most common painkillers—actually works.

For decades, scientists believed that paracetamol relieved pain by working only in the brain and spinal cord. But this new research, published in PNAS, shows that the drug also works outside the brain, in the nerves that first detect pain.

Their discovery centers on a substance called AM404, which the body makes after taking paracetamol. The team found that AM404 is produced right in the pain-sensing nerve endings—and that it works by shutting off specific channels (called sodium channels) that help transmit pain signals. By blocking these channels, AM404 stops the pain message before it even starts.

“This is the first time we've shown that AM404 works directly on the nerves outside the brain,” said Prof. Binshtok. “It changes our entire understanding of how paracetamol fights pain.”

This breakthrough could also lead to new types of painkillers. Because AM404 targets only the nerves that carry pain, it may avoid the numbness, muscle weakness, and side effects that come with traditional local anesthetics.

“If we can develop new drugs based on AM404, we might finally have pain treatments that are highly effective but also safer and more precise,” added Prof. Priel.

The study, “The analgesic paracetamol metabolite AM404 acts peripherally to directly inhibit sodium channels,” appears in the June 2025 issue of PNAS, a leading journal of the U.S. National Academy of Sciences and can be accessed at: https://www.pnas.org/doi/10.1073/pnas.2413811122
Researchers:
Yossef Maatuf1, Yishai Kushnir2,3, Alina Nemirovski4, Mariana Ghantous1, Ariel Iskimov1, Alexander M. Binshtok2,3, Avi Priel1
Institutions:
1. The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem
2. Department of Medical Neurobiology, Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem
3. The Edmond and Lily Safra Center for Brain Sciences (ELSC), The Hebrew University of Jerusalem
4. Mass Spectrometry Unit, The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem

Regions: Middle East, Israel, North America, United States
Keywords: Health, Medical, Science, Life Sciences

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Referenzen

We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet
AlphaGalileo is a great source of global research news. I use it regularly.
Robert Lee Hotz, LA Times

Wir arbeiten eng zusammen mit...


  • e
  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2025 by DNN Corp Terms Of Use Privacy Statement